Unicyte Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $66.6M

  • Investors
  • 1

Unicyte General Information

Description

Operator of a transformative regenerative medicine company intended to advance stem cell technologies into a novel class of human therapeutics. The company has developed a broad preclinical pipeline in key therapeutic areas of human liver stem cells, functional pancreatic islets, and nano-extracellular vesicles, enabling doctors to improve the lives of patients with kidney or liver disease, diabetes, and cancer.

Contact Information

Website
www.unicyte.ch
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Aawasserstrasse 2
  • Nidwalden
  • 6370 Oberdorf
  • Switzerland
+41 041
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Aawasserstrasse 2
  • Nidwalden
  • 6370 Oberdorf
  • Switzerland
+41 041

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Unicyte Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 05-Sep-2019 $66.6M Completed Clinical Trials - Phase 2
To view Unicyte’s complete valuation and funding history, request access »

Unicyte Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a transformative regenerative medicine company intended to advance stem cell technologies into a novel class
Drug Discovery
Oberdorf, Switzerland
14 As of 2025

Galway, Ireland
 

Winston-Salem, NC
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Unicyte Competitors (3)

One of Unicyte’s 3 competitors is Orbsen Therapeutics, a Private Equity-Backed company based in Galway, Ireland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Orbsen Therapeutics Private Equity-Backed Galway, Ireland
ProKidney Corporation Winston-Salem, NC
Evox Therapeutics Venture Capital-Backed Oxford, United Kingdom
You’re viewing 3 of 3 competitors. Get the full list »

Unicyte Patents

Unicyte Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4534649-A1 A method of qualifying as pharmaceutically active a batch of undifferentiated adult stem cells having the potential to differentiate along the hepatic lineage Inactive 03-Oct-2023
WO-2025074243-A1 A method of qualifying as pharmaceutically active a batch of undifferentiated adult stem cells having the potential to differentiate along the hepatic lineage Inactive 03-Oct-2023

Unicyte Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Unicyte Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fresenius Medical Care Corporation Minority
To view Unicyte’s complete investors history, request access »

Unicyte FAQs

  • When was Unicyte founded?

    Unicyte was founded in 2015.

  • Where is Unicyte headquartered?

    Unicyte is headquartered in Oberdorf, Switzerland.

  • What is the size of Unicyte?

    Unicyte has 14 total employees.

  • What industry is Unicyte in?

    Unicyte’s primary industry is Drug Discovery.

  • Is Unicyte a private or public company?

    Unicyte is a Private company.

  • What is Unicyte’s current revenue?

    The current revenue for Unicyte is .

  • How much funding has Unicyte raised over time?

    Unicyte has raised $66.6M.

  • Who are Unicyte’s investors?

    Fresenius Medical Care has invested in Unicyte.

  • Who are Unicyte’s competitors?

    Orbsen Therapeutics, ProKidney, and Evox Therapeutics are competitors of Unicyte.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process